Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209297 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yuqing Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Eye and Vision Research (CEVR), 17W Hong Kong, Science Park, Hong Kong. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Oxidative Stress, Dry Eye Syndromes, Muramidase. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shaanxi Huikang Biotech Co., Ltd., The Hong Kong Polytechnic University.
Abstract (Originalsprache)
Given the escalating global prevalence of dry eye disease (DED) and the inadequacy of current palliative management, this study was to evaluate thetherapeutic potential of recombinant lysozyme (rlysozyme) and investigate underlying mechanisms. Human corneal epithelial cells (HCEC) were subjected to hyperosmotic stress and treated with graded rlysozyme. Cell viability, wound healing, barrier integrity, oxidative stress, cytokines, and mitochondrial function were evaluated by MTS and scratch assays, immunofluorescent staining, ELISA, qRT-PCR, and flow cytometry. Results: No cytotoxicity was observed at any of the tested concentrations (2.76 × 10−9–2.76 × 10−4 M) in HCEC. In hyperosmolarity-induced DED cells, rlysozyme at the highest concentrations (2.76 × 10−4 M) significantly increased cell viability by 12.30% (p < 0.001) and promoted corneal repair by 45.04% (p < 0.05), which were comparable to those of 0.4% hyaluronic acid (the positive control). It also improved via restoring ZO-1 organization. Mechanistically, qRT-PCR results revealed that rlysozyme reduced mRNA expression of IL-1β (by 28.7%), TNF (by 39.2%) and key NLRP3 inflammasome components, including NLRP3 (by 62.0%) and PYD and CARD domain-containing protein gene(PYCARD, 21.4%), while caspase-1 (CASP1) and IL-6 expression remained unchanged. Moreover, oxidative stress was attenuated, as evidenced by significant decreases in reactive oxygen species (ROS, by 59.1%), 8-hydroxy-2-deoxyguanosine levels (8-OHdG, by 23.6%) and total matrix metalloproteinase-9 (MMP-9, by 64.3%) protein levels (p < 0.001), while mitochondrial membrane potential was assessed qualitatively. In conclusion, this study demonstrates thatrlysozyme effectively enhanced corneal epithelial cell viability, promoted wound healing, and restored ZO-1 structural organization without inducing cytotoxicity. These protective effects were associated with downregulation of NLRP3 inflammasome-related genes and attenuation of oxidative stress, supporting further investigation of its therapeutic potential in DED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Eye and Vision Research (CEVR), 17W Hong Kong, Science Park, Hong Kong.
- PolyU-HuiKang Joint Laboratory, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
- School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
- Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
ORCID-Profile: Yuqing Jiang, Weili Hu, Chi Wai Do, Man Sau Wong, Liping Zhou
Förderung
- Shaanxi Huikang Biotech Co., Ltd.
- The Hong Kong Polytechnic University
Zitieren
APA
Jiang, Y., Hu, W., Yi, L., Thacker, M., Wu, Q., Li, Y., Gao, E., Bian, J., Do, C. W., Lam, T. C., Wong, M. S., & Zhou, L. (2026). Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209297
Vancouver
Jiang Y, Hu W, Yi L, Thacker M, Wu Q, Li Y, et al. Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209297
BibTeX
@article{Jiang2026,
author = {Jiang, Yuqing and Hu, Weili and Yi, Lingxiao and Thacker, Minal and Wu, Qiyun and Li, Yuan and Gao, En and Bian, Jingfang and Do, Chi Wai and Lam, Thomas Chuen and Wong, Man Sau and Zhou, Liping},
title = {Recombinant Human Lysozyme Attenuates Hyperosmolarity-Induced Dry Eye Disease by Suppressing Oxidative Stress and Modulating NLRP3 Inflammasome Signaling},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209297}
}
EUVIMED